Reply to comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer

Affiliations

¹ Department of Radiation Oncology, University of Washington, Seattle, Washington.
² Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
³ Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Comment

Lia M Halasz et al. Cancer. 2016.

. 2016 Oct 15;122(20):3244-3245.

doi: 10.1002/cncr.30187. Epub 2016 Jul 8.

¹ Department of Radiation Oncology, University of Washington, Seattle, Washington.
² Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
³ Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

No abstract available

Comment on

Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.
Halasz LM, Uno H, Hughes M, D'Amico T, Dexter EU, Edge SB, Hayman JA, Niland JC, Otterson GA, Pisters KM, Theriault R, Weeks JC, Punglia RS. Halasz LM, et al. Cancer. 2016 Jul 1;122(13):2091-100. doi: 10.1002/cncr.30009. Epub 2016 Apr 18. Cancer. 2016. PMID: 27088755 Free PMC article.
Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.
Miller JA, Kotecha R, Suh JH. Miller JA, et al. Cancer. 2016 Oct 15;122(20):3243-3244. doi: 10.1002/cncr.30188. Epub 2016 Jul 8. Cancer. 2016. PMID: 27392066 No abstract available.